Rockville MD; Sept. 30, 2004 - The Biotechnology information Institute has published the third edition of BIOPHARMA: Biopharmaceutical Products in the U.S. Market (visit www.biopharma.com). BIOPHARMA is the only comprehensive reference book concerning biopharmaceuticals. The 3rd edition, 788 pages, provides in-depth monographs for over 350 products. BIOPHARMA includes all recombinant and other proteins, monoclonal antibodies, vaccines, enzymes, blood products, toxins, and cultured cells and tissues. Emphasis is on the products' biotechnology and commercial aspects - composition, activity, nomenclature, companies involved and relationships, manufacturing methods, patents/technology transfer, regulatory history/status, approved indications, market size/share, controversial aspects, etc. BIOPHARMA is fully up-to-date to mid-August 2004.

BIOPHARMA is more than just a directory. Besides detailed product descriptions, monographs include technological, competitive, marketing and regulatory intelligence and assessments. In-depth indexing (over 40 terms/product) provides unprecedented access to biopharmaceutical products and companies. Indexes include Product Nomenclature, Class, Biological, Chemical, Medical, Regulatory/Status, and Approval Date; and Company, Company Role, State/Country, and Marketing Territory. The public database at www.biopharma.com provides considerable free information, and is a value-added feature for book owner/users who can search online and read the full monographs in the book.

The 3rd edition, ISBN: 0-9639573-3-3, costs $260 plus shipping ($15 U.S.; $45 international). For further information or to place an order, visit http://www.BIOPHARMA.com; or contact the author/publisher: Ron Rader, Biotechnology Information Institute; E-mail: info@biopharma.com; Phone: 301-424-0255.